FDA Label for Rohto Digi-eye

View Indications, Usage & Precautions

Rohto Digi-eye Product Label

The following document was submitted to the FDA by the labeler of this product The Mentholatum Company. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.

Active Ingredients



Hypromellose 0.35%

Tetrahydrozoline hydrochloride 0.05%


Purpose



Hypromellose - Lubricant

Tetrahydrozoline hydrochloride - Redness reliever


Uses



  • •temporarily relieves burning and irritation due to dryness of the eye
  • •relieves redness of the eye due to minor eye irritations

Warnings



For external use only


Ask A Doctor Before Use If You Have



narrow angle glaucoma


When Using This Produce



  • •do not touch tip of container to any surface to avoid contamination
  • •replace cap after each use
  • •do not use if solution changes color or becomes cloudy
  • •overuse may cause more eye redness
  • •pupils may become enlarged temporarily
  • •remove contact lenses before using

Stop Use And Ask A Doctor If



  • •you feel eye pain
  • •changes in vision occur
  • •redness or irritation of the eyes lasts
  • •condition worsens or lasts more than 72 hours

Keep Out Of Reach Of Children.



If swallowed, get medical help or contact a Poison Control Center right away.


Directions



  • •put 1 or 2 drops in the affected eye(s) up to 4 times daily
  • •tightly snap on cap to seal
  • Other information

    • •do not store above at 25°C (77°F)

Inactive Ingredients



benzalkonium chloride, boric acid, chlorobutanol, cyanocobalamin, edetate disodium, menthol, polysorbate 80, potassium aspartate, purified water, pyridoxine hydrochloride, sodium borate


Questions Or Comments?



1-877-636-2677 MON-FRI 9AM to 5PM (EST)


* Please review the disclaimer below.